Ategrity Specialty Insurance Company Holdings (ASIC) - a $1.7 billion-asset specialty property and casualty insurer writing exclusively in the excess and surplus (E&S) market for small and medium-sized businesses - delivered its first full quarter as a public company with the kind of result that the post-IPO specialty insurance crowd has spent two years waiting to see. Q2 net earned premiums of $113.8 million grew 30.9% year over year, gross written premiums of $206.8 million grew 23.4%, the combined ratio improved roughly three full points to 85.9%, and net income attributable to stockholders nearly doubled to $33.5 million, with diluted earnings per share of $0.67 GAAP and $0.67 adjusted. Underwriting income of $16.0 million was up 66.9% - the cleanest read on the underlying engine, and the part of the print most likely to persist. A $50 million share repurchase authorization, the first use of which retired 142,686 shares at an average $19.87 during the quarter, is a third of the company voting, in its first 90 days of public life, that its own stock is the most compelling use of capital at the current price.
There is a separate, less flattering fact to acknowledge up front: the company is controlled. Founder and chairman Stuart J. Zimmer beneficially owns 83.7% of the common stock through Zimmer Financial Services Group LLC (ZFSG), the same parent that provides the company's tax filing, technology licensing, investment management, and shared services infrastructure. The chair's stake is the reason the company can run with the operating leverage it just printed, and the reason minority investors must accept that the most consequential capital and related-party decisions are made by a single related party. The market has priced that discount into the stock: at $25.07, ASIC trades at roughly 1.8x book value of $13.86 per share and roughly 9x annualized Q2 net income - multiples that look cheap against a 20.7% annualized return on stockholders' equity, and that are only coherent if the controller overhang stays put.
The thesis, in one line: a profitable, fast-growing E&S specialty insurer in its first full public quarter, expanding at industry-leading rates with a combined ratio moving in the right direction, trading at a 20%–25% discount to book for a reason that is corporate-structure rather than operational. The falsification is not whether growth continues - it will, at least through the first half of FY2027 - but whether the parent either sells down the position meaningfully or the company grows into the multiple on its own, the way Kinsale Capital and James River Group did. The next report reads that clock.